Browsing by Author Tam, Constantine

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Ibrutinib for patients with rituximab-refractory Waldenstrom's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trialTrotman, Judith; Dimopoulos, Meletios Athanassios; et al, Various; Heffner, L; Ma, Shuo; Macdonald, D; Matous, J; Oriol, Albert; Tam, Constantine; Tedeschi, A; Tournilhac, O; Concord Clinical School: MedicineIbrutinib for patients with rituximab-refractory Waldenstrom's macroglobulinaemia (iNNOVATE): an open-label substudy of an international, multicentre, phase 3 trial, The Lancet Oncology, vol.18, 2, 2017,pp 241-250
2015Practical management of myelofibrosis with ruxolitinibHo, Joy Phoebe; Stevenson, William; Bird, Robert; Dunlop, L; Durrant, S; Marlton, Paula V; Ritchie, D; Ross, David M; Tam, Constantine; Central Clinical School: Medicine; Northern Clinical School: MedicinePractical management of myelofibrosis with ruxolitinib, Internal Medicine Journal, vol.45, 12, 2015,pp 1221-1230
2017Treatment of patients with Waldenstrom macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupGibson, John; Ho, Joy Phoebe; Joshua, Douglas; Trotman, Judith; Ward, Christopher; et al, Various; Harrison, Simon; Horvath, Noemi; Lee, Cindy; Mollee, Peter N; Quach, Hang; Roberts, Andrew; Spencer, Andrew; Szer, Jeff; Talaulikar, Dipti; Tam, Constantine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Northern Clinical School: Kolling InstituteTreatment of patients with Waldenstrom macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory Group, Internal Medicine Journal, vol.47, 1, 2017,pp 35-49